"Momordica balsamina: A medicinal and neutraceutical plant for health care management". Comments: Biotechnological potential of M. balsamina revealed

Current Pharmaceutical Biotechnology

Volumn 11, Issue 2, 2010, Pages 229-

  Puri, Munish ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; MOMORDIN;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; HYPOGLYCEMIA; LETTER; LIVER PROTECTION; MOMORDICA; MOMORDICA BALSAMINA; NONHUMAN;

BIOTECHNOLOGY; DELIVERY OF HEALTH CARE; DIETARY SUPPLEMENTS; MOMORDICA; PLANT PREPARATIONS; PLANTS, MEDICINAL;

MOMORDICA BALSAMINA;

EID: 77949907404     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110790909696     Document Type: Letter

References (4)

1. Puri, M.; Kaur, I.; Kanwar, R.K.; Gupta, R.C.; Chauhan, A.; Kanwar, J.R. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Curr. Mol. Med., 2009, 9,1080-1094.
2. Lee, D.K.; Kim, B.; Lee, S.K.; Gwon, H.J.; Moon, E.Y.; Whang, H.S.; Seong, S.K.; Lee, M.;Sung, H.J.; Lim, M.J.; Sin, D.H.; Yoon, S.J.; Yang, C.H. Momordins inhibit both AP-1 function and cell proliferation. Anticancer Res., 1998, 18, 119-124.
3. Husain, J.; Tickle, I.J.; Wood, S.P. Crystal structure of momordin, a type I ribosome inactivating protein from the seeds of Momordica charantia. FEBS Lett., 1994, 342, 154-158.
4. Ramalhete, C.; Mansoor, T.A.; Mulhove, S.; Molnar, J.; Ferreira, M.J. Cucurbitane-type triterpenoids from the African plant Momordica balsamina. J. Nat. Prod., 2009, 72, 2009-2013.